DavidAlexanderLeafMDMPH
Internal Medicine • Los Angeles, CAProfessor of Medicine, David Geffen School of Medicine at UCLA
Are you Dr. Leaf?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 23 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11301 Wilshire Blvd
111G
Los Angeles, CA 90073Phone+1 310-478-3711Fax+1 310-268-4933
Summary
- Dr. David Leaf, MD is an internist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Greater Los Angeles HCS and is a Professor of Medicine at David Geffen School of Medicine at UCLA.
Education & Training
Oregon Health Science University HospitalFellowship, Clinical Nutrition, 1984 - 1985
Legacy Health/Emanuel Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Washington School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1987 - 2018
Publications & Presentations
PubMed
- 10 citationsComparative Effectiveness of Diabetic Oral Medications Among HIV-Infected and HIV-Uninfected Veterans.Jennifer H. Han, Kirsha S. Gordon, Julie A. Womack, Cynthia L. Gibert, David A. Leaf
Diabetes Care. 2017-02-01 - 31 citationsAssociation Between Depressive Disorders and Incident Acute Myocardial Infarction in Human Immunodeficiency Virus-Infected Adults: Veterans Aging Cohort StudyTasneem Khambaty, Jesse C. Stewart, Samir K. Gupta, Chung-Chou H. Chang, Roger Bedimo
JAMA Cardiology. 2016-11-01 - 104 citationsWeight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals.Melissa A. Herrin, Janet P. Tate, Kathleen M. Akgün, Adeel A. Butt, Kristina Crothers
Journal of Acquired Immune Deficiency Syndromes. 2016-10-01
Press Mentions
Peter McCullough Tells AllDecember 16th, 2021- The Drug Tocilizumab for Rheumatoid Arthritis Is Insufficient in the Treatment of Covid-19 Patients in Hospital in Three StudiesOctober 22nd, 2020
- New Results from a Once-Promising Therapy Show the Difficulty of Treating COVID-19October 22nd, 2020
- Join now to see all
